[1]
“COUMARIN DERIVATIVE TREATMENT: AN OBESERVATIONAL PROSPECTIVE STUDY TO ASSESS INCIDENCE OF ELEVATED INR, ITS ASSOCIATED RISK FACTORS AND THE PATIENT ADHERENCE ”, Journal of Pharmaceutical Negative Results, pp. 970–983, Dec. 2022, doi: 10.47750/pnr.2022.13.S10.111 .